Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martial Hamon

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Circulation|February 10, 2010
Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization And Urgent Intervention Triage Strategy (ACUITY) substudyKenji Goto, Alexandra J Lansky, Martin Fahy, et al.
JACC. Cardiovascular Interventions|February 26, 2011
Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary interventionFreek W A Verheugt, Steven R Steinhubl, Martial Hamon, et al.
The American Journal of Cardiology|October 15, 2014
Prognostic value of angiographic lesion complexity in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the acute catheterization and urgent intervention triage strategy trial)Kenji Goto, Alexandra J Lansky, Vivian G Ng, et al.
Journal of the American College of Cardiology|March 31, 2007
Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY TrialSteven V Manoukian, Frederick Feit, Roxana Mehran, et al.
Cardiovascular Drugs and Therapy|June 19, 2008
Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel (3T/2R). Rationale for the study and protocol designMarco Valgimigli, Gianluca Campo, Nicoletta de Cesare, et al.
Circulation. Cardiovascular Interventions|June 10, 2015
Impact of arterial access site on outcomes after primary percutaneous coronary intervention: prespecified subgroup analysis from the EUROMAX trialMartial Hamon, Pierre Coste, Arnoud Van't Hof, et al.
JACC. Cardiovascular Interventions|July 23, 2013
Costs of transradial percutaneous coronary interventionAmit P Amin, John A House, David M Safley, et al.
JACC. Cardiovascular Interventions|January 25, 2015
Acute stent thrombosis after primary percutaneous coronary intervention: insights from the EUROMAX trial (European Ambulance Acute Coronary Syndrome Angiography)Peter Clemmensen, Sebastian Wiberg, Arnoud Van't Hof, et al.
Journal of Interventional Cardiology|March 11, 2004
Initial and follow-up results of the European Seaquence coronary stent registryMartial Hamon, Virgil Petrescu, Philippe Rossi, et al.
Circulation|May 2, 2007
Clinical end points in coronary stent trials: a case for standardized definitionsDonald E Cutlip, Stephan Windecker, Roxana Mehran, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Circulation|February 10, 2010
Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization And Urgent Intervention Triage Strategy (ACUITY) substudyKenji Goto, Alexandra J Lansky, Martin Fahy, et al.
JACC. Cardiovascular Interventions|February 26, 2011
Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary interventionFreek W A Verheugt, Steven R Steinhubl, Martial Hamon, et al.
The American Journal of Cardiology|October 15, 2014
Prognostic value of angiographic lesion complexity in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the acute catheterization and urgent intervention triage strategy trial)Kenji Goto, Alexandra J Lansky, Vivian G Ng, et al.
Journal of the American College of Cardiology|March 31, 2007
Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY TrialSteven V Manoukian, Frederick Feit, Roxana Mehran, et al.
Cardiovascular Drugs and Therapy|June 19, 2008
Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel (3T/2R). Rationale for the study and protocol designMarco Valgimigli, Gianluca Campo, Nicoletta de Cesare, et al.
Circulation. Cardiovascular Interventions|June 10, 2015
Impact of arterial access site on outcomes after primary percutaneous coronary intervention: prespecified subgroup analysis from the EUROMAX trialMartial Hamon, Pierre Coste, Arnoud Van't Hof, et al.
JACC. Cardiovascular Interventions|July 23, 2013
Costs of transradial percutaneous coronary interventionAmit P Amin, John A House, David M Safley, et al.
JACC. Cardiovascular Interventions|January 25, 2015
Acute stent thrombosis after primary percutaneous coronary intervention: insights from the EUROMAX trial (European Ambulance Acute Coronary Syndrome Angiography)Peter Clemmensen, Sebastian Wiberg, Arnoud Van't Hof, et al.
Journal of Interventional Cardiology|March 11, 2004
Initial and follow-up results of the European Seaquence coronary stent registryMartial Hamon, Virgil Petrescu, Philippe Rossi, et al.
Circulation|May 2, 2007
Clinical end points in coronary stent trials: a case for standardized definitionsDonald E Cutlip, Stephan Windecker, Roxana Mehran, et al.
Pageof 10